Vimarsana
Biggest News Aggregation in the World

Page 38 - Technology Licensing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Licensing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Licensing Today - Breaking & Trending Today

Baird Financial Group Inc. Buys 16,515 Shares of Microchip Technology Incorporated (NASDAQ:MCHP) - Vimarsana News

Baird Financial Group Inc. Buys 16,515 Shares of Microchip Technology Incorporated (NASDAQ:MCHP)

Baird Financial Group Inc. boosted its stake in Microchip Technology Incorporated (NASDAQ:MCHP – Get Rating) by 4.0% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 425,307 shares of the semiconductor company’s stock after purchasing an additional 16,515 shares during the quarter. Baird Financial Group Inc.’s holdings in Microchip Technology were worth $25,956,000 at the […]

BioNJ Announces Lineup for BioPartnering Conference - Vimarsana News

BioNJ Announces Lineup for BioPartnering Conference

/PRNewswire/ -- BioNJ is pleased to host its 13th Annual BioPartnering Conference on Tuesday, April 18, 2023, at The Palace at Somerset Park, Somerset, NJ....

Global Advances in Gene Editing Technologies in Healthcare Market Report 2023: CRISPR, ZFNs, and TALENs have Revolutionized the Gene Editing Field - Vimarsana News

Global Advances in Gene Editing Technologies in Healthcare Market Report 2023: CRISPR, ZFNs, and TALENs have Revolutionized the Gene Editing Field

/PRNewswire/ -- The "Advances in Gene Editing Technologies in Healthcare" report has been added to ResearchAndMarkets.com's offering. CRISPR, ZFNs, and TALENs...

Princeton's technology accelerator fund celebrates 22 startups in 10 years of fueling innovations - Vimarsana News

Princeton's technology accelerator fund celebrates 22 startups in 10 years of fueling innovations

The Intellectual Property (IP) Accelerator Fund provides support to researchers who have made a discovery but need to conduct extra studies to demonstrate that the discovery can meet a societal need.

Antibody-drug Conjugates Growth Opportunities 2022: Disruptive Technologies and a Conducive Funding Environment are Fostering Growth - Vimarsana News

Antibody-drug Conjugates Growth Opportunities 2022: Disruptive Technologies and a Conducive Funding Environment are Fostering Growth

/PRNewswire/ -- The "Antibody-drug Conjugates: Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. Antibody-drug...